The Role of L-arginine in Polycystic Ovary Syndrome

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 14, 2024

Primary Completion Date

July 4, 2025

Study Completion Date

July 4, 2025

Conditions

Polycystic Ovary SyndromeL-arginineGut Microbiome

Interventions

DRUG

L-arginine intervention

L-arginine intervention for 3 months, 3 g per day.

Trial Locations (2)

Department of Endocrinology, Shanghai Tenth People's Hospital, Shanghai

Shanghai Tenth People's Hospital, Shanghai

All Listed Sponsors

lead

Shanghai 10th People's Hospital

OTHER

NCT06728644 - The Role of L-arginine in Polycystic Ovary Syndrome | Biotech Hunter | Biotech Hunter